Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
BMC Oral Health ; 24(1): 335, 2024 Mar 14.
Article in English | MEDLINE | ID: mdl-38486235

ABSTRACT

BACKGROUND: Several efforts have been made to improve mechanical and biological properties of calcium silicate-based cements through changes in chemical composition of the materials. This study aimed to investigate the physical (including setting time and compressive strength) and chemical (including calcium ion release, pH level) properties as well as changes in cytotoxicity of mineral trioxide aggregate (MTA) after the addition of 3 substances including CaCl2, Na2HPO4, and propylene glycol (PG). METHODS: The systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Electronic searches were performed on PubMed, Embase, and Scopus databases, spanning from 1993 to October 2023 in addition to manual searches. Relevant laboratory studies were included. The quality of the included studies was assessed using modified ARRIVE criteria. Meta-analyses were performed by RevMan statistical software. RESULTS: From the total of 267 studies, 24 articles were included in this review. The results of the meta-analysis indicated that addition of PG increased final setting time and Ca2+ ion release. Addition of Na2HPO4 did not change pH and cytotoxicity but reduced the final setting time. Incorporation of 5% CaCl2 reduced the setting time but did not alter the cytotoxicity of the cement. However, addition of 10% CaCl2 reduced cell viability, setting time, and compressive strength. CONCLUSION: Inclusion of 2.5% wt. Na2HPO4 and 5% CaCl2 in MTA can be advisable for enhancing the physical, chemical, and cytotoxic characteristics of the admixture. Conversely, caution is advised against incorporating elevated concentrations of PG due to its retarding effect. TRIAL REGISTRATION: PROSPERO registration number: CRD42021253707.


Subject(s)
Aluminum Compounds , Calcium Compounds , Oxides , Silicates , Aluminum Compounds/toxicity , Aluminum Compounds/chemistry , Calcium Chloride/pharmacology , Dental Cements/toxicity , Dental Cements/chemistry , Drug Combinations , Oxides/toxicity , Oxides/chemistry , Propylene Glycol/chemistry
2.
GMS Hyg Infect Control ; 19: Doc04, 2024.
Article in English | MEDLINE | ID: mdl-38404412

ABSTRACT

Background: The vaccination is one of the acceptable and recomended solution to prevent and control of COVID-19. The aim of this study was to determine the efficacy of sinopharm vaccination in children aged 12-17 in Tehran. Methods: The case population study was performed from October 2021 to March 2022 among 1,500 children with positive PCR test reffered in Mofid Children's Hospital in Tehran. 64 children aged 12-17 years were included. The data were collected by the hospital information system (HIS), vaccination information registration systems and questionnaire with their families. The coverage and efficacy of vaccination determined with equels commented by WHO. Results: Out of 64 children, 52 children were 12 to 15 years old (13.35±1.08), 12 children were 16 to 17 years old (16.55±0.52). 48.4% had received two doses of vaccine. The highest rate of positive PCR was observed in February 2022. Sinopharm vaccine coverage in this age group was 93.6% for the first dose and 81.1% for the second dose. Based on this information, 48.4% children in this study have received two complete doses of the COVID-19 vaccine. The efficacy of the vaccine was estimated as 94.4% (95% CI 90.2 to 97.7). Conclusion: It seems the coverage of Sinopharm vaccination in the age group of 12-17 years in Tehran is favorable and has high efficacy in this age group. In order to obtain more accurate and comprehensive estimation, it is recommended to take a sample on a wider level of the community.

3.
PLoS One ; 18(11): e0293843, 2023.
Article in English | MEDLINE | ID: mdl-37943824

ABSTRACT

OBJECTIVE: The present study aimed to identify the social cognitive predictors of regular dental visits and mouth self-examination behaviors among the elderly population, based on the Health Action Process Approach (HAPA) model. BACKGROUND: Regular dental visits and mouth self-examination can prevent oral and dental problems among the elders. Little information is available regarding the social cognitive predictive factors of these two behaviors. MATERIALS AND METHODS: A cross-sectional study was conducted in 24 municipality centers in Tehran, Iran in 2021. The centers were selected randomly using a multi-stage cluster sampling method and 301 elderly attendants aged 60≥years participated in the study. Data collection was done using a researcher-made questionnaire including demographic characteristics and the HAPA model constructs for two target behaviors. Data were analyzed using the Smart-PLS version 3.3.9 via correlation and PLS-SEM analysis. RESULTS: The mean age of the participants was 65.3±5.33 years and 79.7% were female. The SEM analysis showed that Action Self-Efficacy [b (SD) = 0.595 (0.065), P< 0.001] and Risk Perception [b (SD) = 0.218 (0.070), P< 0.002] were predictors of Intention for mouth self-examination but only Action Self-Efficacy [b (SD) = 0.651 (0.043), P< 0.001] was predictor of Intention for regular dental visits. Recovery Self-Efficacy and Planning directly contributed to the prediction of Mouth Self-Examination. The relationship between Maintenance Self-Efficacy and both behaviors is mediated by Planning. Also, the mediating role of Planning between Intention and target behaviors was confirmed. CONCLUSION: Action self-efficacy predicted the intention for regular dental visits and mouth self-examination behaviors. The relationship between intention and both behaviors was mediated by Planning. Emphasis on improving Action Self-Efficacy and Intention formation will enhance the effectiveness of interventions aiming at promoting the oral health of the elderly population.


Subject(s)
Intention , Self-Examination , Humans , Aged , Female , Middle Aged , Male , Cross-Sectional Studies , Iran , Surveys and Questionnaires , Self Efficacy , Cognition
4.
PLoS One ; 18(11): e0293428, 2023.
Article in English | MEDLINE | ID: mdl-38011147

ABSTRACT

AIM: According to the World Health Organization (WHO), early childhood caries (ECC) is still considered a major global health problem despite the general improvement in oral health practice. This study aimed to assess ECC's prevalence, severity, and key social and behavioral determinants in Iranian children 1-5- years of age. METHOD: This cross-sectional study recruited Iranian 1-5-year-olds with a three-stage stratified clustered sampling method. After providing consent, parents were interviewed using a validated questionnaire, including questions on child characteristics and behavioral factors. Each child underwent a dental examination by one of four trained and calibrated dentists. Associations between key covariates of interest and primary outcome measures were assessed by multivariable logistic regression modeling and multivariate generalized negative binomial regression modeling after weightings were applied. Statistical analysis was performed using SPSS V25 and Stata V14.2 software packages. A p-value ≤ 0.05 was considered significant. RESULTS: The mean age of 909 participants was 41.1±1.2 months, 48.6% were male, and 38.1% lived in rural areas. The overall prevalence of ECC was 53.2% and mean dmft score was 2.7± 0.3. Key determinants associated with ECC included living rurally (p = 0.009, OR = 2.13), consuming sweet drinks, sugary snacks, or both [p-value = 0.02 (OR = 2.53), and p-value<0.001 (OR = 4.96), respectively], and visible plaque (p<0.001, OR = 3.41). Covariates associated with dmft scores included residing in rural regions (p = 0.02, IRR = 1.31), having both sugary snacks and sweet drinks (p = 0.02, IRR = 1.85) compared to those had none, and visible dental plaque (p<0.001, IRR = 2.06). CONCLUSIONS: The prevalence of dental caries in children is high in Iran. The increase of ECC prevalence and severity from toddlers to preschoolers emphasizes on the critical importance of early interventions in toddlers. Improving access to care for rural children is essential along with the need to change dietary and self-care behaviors through multilevel efforts.


Subject(s)
Dental Caries , Humans , Male , Child, Preschool , Infant , Female , Iran/epidemiology , Dental Caries/epidemiology , Prevalence , Cross-Sectional Studies , Dental Caries Susceptibility
5.
Int J Hematol Oncol Stem Cell Res ; 17(2): 81-88, 2023 Apr 01.
Article in English | MEDLINE | ID: mdl-37637767

ABSTRACT

BACKGROUND: FAT atypical cadherin 1 (FAT1) is a member of the cadherin superfamily whose loss or gain is associated with the initiation and/or progression of different cancers. FAT1 overexpression has been reported in hematological malignancies. This research intended to investigate FAT1 gene expression in adult Iranian acute leukemia patients, compared to normal mobilized peripheral blood CD34+ cells. MATERIALS AND METHODS: The peripheral blast (peripheral blood mononuclear cells) cells of 22 acute myeloid leukemia (AML), 14 acute lymphoid leukemia (ALL) patients, and mobilized peripheral blood CD34+ cells of 12 healthy volunteer stem cell donors were collected. Then, quantitative real-time polymerase chain reaction (qPCR) was used to compare FAT1 gene expression. RESULTS: Overall, there were no significant differences in FAT1 expression between AML and ALL patients (p>0.2). Nonetheless, the mean expression level of FAT1 was significantly higher in leukemic patients (AML and ALL) than in normal CD34+ cells (p=0.029). Additionally, the FAT1 expression levels were significantly higher in both CD34+ and CD34- leukemic patients than in normal CD34+ cells (p=0.028). CONCLUSION: No significant differences were found between FAT1 expression in CD34+ and CD34- leukemic samples (p> 0.3). Thus, higher FAT1 expression was evident in ALL and AML leukemia cells but this appeared unrelated to CD34 expression. This suggests in a proportion of adult acute leukemia, FAT1 expression may prove to be a suitable target for therapeutic strategies.

6.
Dent Res J (Isfahan) ; 20: 19, 2023.
Article in English | MEDLINE | ID: mdl-36960026

ABSTRACT

Background: The present study was conducted to develop a standard questionnaire to assess the knowledge and practice of prosthodontists regarding the diagnosis and treatment of obstructive sleep apnea syndrome (OSA). Materials and Methods: This study had questionnaire designing and cross-sectional-descriptive phases. Questionnaire domains were identified by a panel of eight experts. The face and content validity of the questionnaire was assessed by experts and four laypeople. The internal consistency reliability of the questionnaire was checked using Cronbach's alpha coefficient. Moreover, its stability was tested using the test-retest method. The questionnaire was completed online by 282 Iranian prosthodontists and the relationship between different variables and scores of knowledge and practice of them with simple and multiple linear regression tests was were analyzed. Results: A 32-item questionnaire was designed. The Scale Content Validity Index was >0.8 for clarity, simplicity, and necessity in all domains and the content validity of all questions was above 0.8. As for reliability, Cronbach's alpha coefficient was above 0.7 on average. Faculty members had more knowledge (P = 0.04) and better practice (P = 0.001) compared to others. Prosthodontists who participated in sleep disorders training courses had higher scores in knowledge (P = 0.001) and practice (P = 0.001). Prosthodontists who referred patients to sleep disorders clinics had higher knowledge (P = 0.001) and practice (P = 0.001) than those who did not. Conclusion: The questionnaire developed in this study can be considered a comprehensive and executable scale with appropriate reliability and validity. There is a positive relationship between being exposed to information and the level of knowledge and practice of prosthodontists about OSA.

7.
Skin Res Technol ; 29(2): e13284, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36823510

ABSTRACT

BACKGROUND: Brow lift also known as eyebrow lift was first described in 1919, and since then, many changes have been made in the methods of doing it, although there is still no agreed method of absolute superiority for eyebrow lift. Most previous studies have reported the results generally qualitatively and based on patient or surgeon satisfaction. In this study, by combining two less complicated methods of eyebrow lift, we have evaluated the quantitative results. METHOD: Before the surgery, a standard photograph of the face was taken. The vertical distance between the tail of the eyebrow and interpupillary line was determined. RESULTS: This study was performed on 15 females with a mean age of 38.27 ± 6.82 years. The mean distance between the eyebrow and interpupillary line by photographic measurement before surgery, 3 weeks, and 6 months after surgery was, respectively, 10.45 ± 1.74, 15.72 ± 1.77, and 13.53 ± 1.69 mm using the tail of the eyebrow and 18.47 ± 1.67, 23.33 ± 1.57, and 21.55 ± 1.66 mm using the crown of the eyebrow. In the clinical measurement, the eyebrow tail was 11.98 ± 1.75, 19.22 ± 1.73, 17.35 ± 1.68 and 15.13 ± 1.76 mm away from the pupil line, and the crown of eyebrow was 20.45 ± 1.90, 27.12 ± 1.58, 25.00 ± 1.80, and 23.35±1.78 mm. There is a significant difference between the distance of the tail of the eyebrow and the crown of the eyebrow in both measurement methods (photographic and clinical) at different times (p-value <0.001). CONCLUSION: Performing eyebrow lift with the Pretrichial method has many comparative advantages to other methods. Additionally, eyebrow lift with the thread support is a less invasive method.


Subject(s)
Eyebrows , Rhytidoplasty , Female , Humans , Adult , Middle Aged , Rhytidoplasty/methods , Photography
8.
Iran J Child Neurol ; 16(4): 33-44, 2022.
Article in English | MEDLINE | ID: mdl-36478995

ABSTRACT

Objectives: Neuroimaging in high-risk neonates and infants is done to help child neurologists predict the future neurodevelopmental outcome of these children. In this study, we assessed high-risk neonates and infants admitted to the NICU or neonatal wards of Mofid children's Hospital, especially regarding clinical development and brain imaging. Materials & Methods: This cross-sectional study was conducted on 170 patients admitted to the neonatal and NICU ward of Mofid children's Hospital. Considering the inclusion criteria, 112 patients were included in this project. Brain ultrasonography was performed on almost all of these babies by a single radiologist. Some patients underwent a brain CT scan, and brain MRI without contrast was done on the others. These images were interpreted and compared by a single pediatric neuro-radiologist blinded to clinical data. All of these babies were followed up until 18 months of age. Results: In this study, 57.1% of the patients were male and 42.9% were female. Of 44 patients who obtained Electroencephalogram (EEG) during the hospitalization period with probable seizure, 25 (56.8%) had normal EEGs. Of 89 babies who were examined by ultrasound, 19 (21.3%) had abnormal findings; ventriculomegaly and then germinal matrix hemorrhage (GMH) were the most common abnormalities. Also, 27 cases (71.1%) of 38 patients undergoing a CT scan had abnormal findings. The most common findings were a hypodense area in the white matter and ventriculomegaly. Of 41 patients who underwent MRI between 1 and 27 months, 34 cases (82.9%) had an abnormal MRI. The most common findings were periventricular hyperintensities in 17 cases (41.5%), mildly delayed myelination in 15 cases (36.6%), and severe brain atrophy or thinning of corpus callosum or white matter volume loss in seven cases (17.1%). During the follow-up period, which was 18.55 ± 6.56 months, 79 (70.5%) of the children had normal development and 33 (29.5%) were suffering from a global neurodevelopmental delay. More precisely, 49 (43.7%) and 35 (31.2%) patients had motor development delay and delayed verbal development, respectively. The abnormal findings of brain imaging in the ultrasound, CT scan, and MRI were all significantly associated with an adverse neurodevelopmental outcome (P <0.001, P = 0.02, and P <0.001, respectively). Conclusion: In this study, we showed that at any time before six months or after one year of age, the result of brain MRI was a strong predictor of the patient's outcome.

9.
Article in English | MEDLINE | ID: mdl-36141729

ABSTRACT

This study assessed the clinical variables influencing the success of three-unit implant-supported fixed dental prostheses (ISFDPs) fabricated using either fully digital or conventional workflows. The clinical trial evaluated 10 patients requiring three-unit ISFDPs in the posterior mandible. Maxillomandibular relation records, and digital and conventional impressions were obtained from each patient using an intraoral scanner (IoS) and polyvinylsiloxane (PVS), and the frameworks were fabricated using zirconia and cobalt-chromium, respectively. A 2 µm accuracy scanner scanned the conventional master casts and standard reference models. The stereolithography (STL) files of the digital and conventional impressions were superimposed on the standard model file, and the accuracy was calculated with the best-fit algorithm. The framework adaptation and passivity were assessed using the one-screw and screw resistance tests. The time required for occlusal adjustment of both types of reconstructions, including the duration of the whole treatment, was recorded. The aesthetic appearance of ISFDPs was rated by each patient and clinician using a self-administered visual analogue scale questionnaire and the FDI World Dental Federation aesthetic parameters, respectively. The sample size was based on the power calculation, and alpha was set at 0.05 for the statistical analyses. The impression accuracy, framework adaptation and passivity, and reconstructions aesthetics did not significantly differ between the digital and conventional approaches. The total fabrication time was significantly shorter using the digital workflow. Within the limitations of this clinical study, the fully digital workflow can be used for the fabrication of ISFDPs with a clinical outcome comparable to that of the conventional workflow.


Subject(s)
Cobalt , Computer-Aided Design , Chromium , Cross-Over Studies , Humans , Prospective Studies , Workflow
10.
BMC Infect Dis ; 22(1): 625, 2022 Jul 18.
Article in English | MEDLINE | ID: mdl-35850636

ABSTRACT

BACKGROUND: Meningitis is considered a life-threatening infection with high mortality all over the world. Hemophilus influenzae (H. influenzae) and Streptococcus pneumoniae (S. pneumoniae) are regarded as the two most common infectious agents causing bacterial meningitis. This study aimed to identify H. influenzae and S. pneumoniae serotypes in blood and cerebrospinal fluid (CSF) of pediatric patients with meningitis, using polymerase chain reaction (PCR). METHODS: This multi-center cross-sectional study included 284 children with suspected meningitis referred to 4 target hospitals. Overall, 412 samples (128 blood and 284 CSF samples) were obtained from the patients from November 14, 2016 to November 15, 2017. The extracted DNA was examined using multiplex real time PCR to screen for S. pneumoniae and H. influenzae. S. pneumoniae serotyping was also done by multiplex PCR. RESULTS: Out of 284 CSF specimens, 22 were positive for ply S. pneumoniae. Of 20 DNA samples meeting the Quality Control (QC) standards for serotyping, 7 (35%), 6 (30%), 2 (10%), 2 (10%), 2 (10%), 1 (5%), 1 (5%), 1 (5%), 1 (5%) and 1 (5%) were positive for serotypes 3, 11A, 6A, 14, 7C, 23F, 23B, 19A, and 19F and 5, respectively. Overall, nine samples were positive for two serotypes, of whom 3 and 11A were the most common from Tehran province. Of note, one of these CSF samples showed a new co-infection with serotypes 7C and 14. Also, 6 samples (30%) were positive for H. influenzae detected by bexA primer. None of the blood samples were positive for S. pneumoniae or H. influenzae. CONCLUSION: Co-infection with S. pneumoniae serotypes can occur in bacterial meningitis and it might be missed if all serotypes are not evaluated in CSF specimens.


Subject(s)
Coinfection , Meningitis, Bacterial , Child , Coinfection/epidemiology , Cross-Sectional Studies , Haemophilus influenzae/genetics , Humans , Infant , Iran/epidemiology , Meningitis, Bacterial/microbiology , Multiplex Polymerase Chain Reaction , Serogroup , Serotyping , Streptococcus pneumoniae/genetics
11.
Aust N Z J Psychiatry ; 56(9): 1130-1141, 2022 09.
Article in English | MEDLINE | ID: mdl-34996304

ABSTRACT

OBJECTIVE: This review aimed to measure the degree of placebo response in panic disorder. DATA SOURCES: We searched major databases up to 31 January 2021, for randomized pharmacotherapy trials published in English. STUDY SELECTION: A total of 43 studies met inclusion criteria to be in the analysis (with 174 separate outcome measurements). DATA EXTRACTION: Changes in outcome measures from baseline in the placebo group were used to estimate modified Cohen's d effect size. RESULTS: A total of 43 trials (2392 subjects, 174 outcomes using 27 rating scales) were included in the meta-analysis. Overall placebo effect size was 0.57 (95% confidence interval = [0.50, 0.64]), heterogeneity (I2: 96.3%). Higher placebo effect size was observed among clinician-rated scales compared to patient reports (0.75 vs 0.35) and among general symptom and anxiety scales compared to panic symptoms and depression scales (0.92 and 0.64 vs 0.56 and 0.54, respectively). There was an upward trend in effect size over the publication period (r = 0.02, p = 0.002) that was only significant among clinician-rated scales (r = 0.02, p = 0.011). There was no significant publication bias, Egger's test (p = 0.08). CONCLUSION: We observed a substantial placebo effect size in panic disorder. This effect was more prominent for some aspects of panic disorder psychopathology than for others and was correlated with the source of the assessment and publication year. This finding has implications both for research design, to address the heterogeneity and diversity in placebo responses, and for clinical practice to ensure optimal quality of care. SYSTEMATIC REVIEW REGISTRATION NUMBER: PROSPERO, CRD42019125979.


Subject(s)
Panic Disorder , Humans , Outcome Assessment, Health Care , Panic Disorder/drug therapy , Placebo Effect , Publication Bias
12.
Indian Pediatr ; 58(12): 1131-1135, 2021 Dec 15.
Article in English | MEDLINE | ID: mdl-34939580

ABSTRACT

BACKGROUND: The pentavalent vaccine Pentavac was officially introduced in the Iranian National Immunization Plan in November, 2014. OBJECTIVE: To compare the immunogenicity and safety of Pentavac vaccine (Serum Institute of India Ltd.) with two other pentavalent vaccines available in Iran, i.e., Pentabio (PT Bio Farma (Persero)) and Shan 5 (Shantha Biotechnics Ltd.). DESIGN: Randomized, phase III study. PARTICIPANTS: 900 infants attending the study sites to receive the vaccine at 2, 4, and 6 months of age. INTERVENTION: Infants were randomly assigned to one of the Pentavac, Pentabio, and Shan 5 vaccine groups. OUTCOMES: The antibody titers were measured against five antigens, diphtheria, tetanus, pertussis, Haemophilus influenzae B, and hepatitis B before receiving the first dose and one month after the last dose. The adverse events following vaccination after each dose were recorded in the adverse events diary. RESULTS: All vaccines showed similar immunogenicity against four of the five antigens except pertussis. While vaccination with Shan 5 resulted in the highest immunogenicity against pertussis, Pentabio was significantly lower than the other two vaccines (P<0.001). The incidence of local adverse events significantly differed among the three vaccine brands (P<0.001), but the incidence of most of the evaluated systemic adverse events was similar (P>0.05). CONCLUSIONS: Pentavac and Shan 5 had similar immunogenicity, the former having better immunogenicity against pertussis than Pentabio. Pentavac and Pentabio had a comparable safety profile.


Subject(s)
Haemophilus Vaccines , Haemophilus influenzae type b , Antibodies, Bacterial , Diphtheria-Tetanus-Pertussis Vaccine , Hepatitis B Vaccines , Humans , Immunization , Infant , Iran , Poliovirus Vaccine, Inactivated , Vaccination/methods , Vaccines, Combined , World Health Organization
13.
Clin Immunol ; 229: 108796, 2021 08.
Article in English | MEDLINE | ID: mdl-34271191

ABSTRACT

INTRODUCTION: Inherited phagocyte defects are one of the subgroups of primary immunodeficiency diseases (PIDs) with various clinical manifestations. As oral manifestations are common at the early ages, oral practitioners can have a special role in the early diagnosis. MATERIALS AND METHODS: A comprehensive search was conducted in this systematic review study and data of included studies were categorized into four subgroups of phagocyte defects, including congenital neutropenia, defects of motility, defects of respiratory burst, and other non-lymphoid defects. RESULTS: Among all phagocyte defects, 12 disorders had reported data for oral manifestations in published articles. A total of 987 cases were included in this study. Periodontitis is one of the most common oral manifestations. CONCLUSION: There is a need to organize better collaboration between medical doctors and dentists to diagnose and treat patients with phagocyte defects. Regular dental visits and professional oral health care are recommended from the time of the first primary teeth eruption in newborns.


Subject(s)
Mouth Diseases/immunology , Phagocytes/immunology , Primary Immunodeficiency Diseases/immunology , Female , GATA2 Deficiency/diagnosis , GATA2 Deficiency/genetics , GATA2 Deficiency/immunology , Granulomatous Disease, Chronic/diagnosis , Granulomatous Disease, Chronic/genetics , Granulomatous Disease, Chronic/immunology , Humans , Male , Mouth Diseases/diagnosis , Mouth Diseases/genetics , Neutropenia/congenital , Neutropenia/diagnosis , Neutropenia/immunology , Papillon-Lefevre Disease/diagnosis , Papillon-Lefevre Disease/genetics , Papillon-Lefevre Disease/immunology , Phagocytes/pathology , Primary Immunodeficiency Diseases/diagnosis , Primary Immunodeficiency Diseases/genetics , Respiratory Burst/genetics , Respiratory Burst/immunology
14.
Biomed Res Int ; 2021: 4923852, 2021.
Article in English | MEDLINE | ID: mdl-33816612

ABSTRACT

BACKGROUND: Haemophilus influenzae (H. influenzae) strains, which commonly reside as commensals within the human pharynx and can remain as an asymptomatic carrier, but become invasive leading to pneumonia, septic arthritis, or meningitis. The Pentavac (pentavalent vaccine, manufactured by India, SII (DTwP-HepB-Hib)) was introduced to the Iranian National Immunization Plan in November 2014. The aim of this study is to investigate H. influenzae type b (Hib) carrier rate among children under 6 years old in Tehran. METHODS: This cross-sectional study was performed on 902 children including vaccinated/unvaccinated in the age of 6 months to 6 years, in Tehran. Sampling was performed from July 2019 to September 2019. Nasopharyngeal samples were taken from children by sterile swab. The PCR method was used to extract DNA. Then, all H. influenzae isolates were initially confirmed by molecular tests. BexA was used to distinguish typeable H. influenzae strains from nontypeable Haemophilus influenzae (NTHi). RESULTS: A total of 902 children were enrolled in the study: 452 were female (51%). H. influenzae carriage rate was 267 (29%), of that 150 samples (16.6%) were typeable. The nasopharyngeal Hib carrier rate in the children was 2.6% (24/902). 262 cases did not receive Hib vaccine. Analysis in nonnursery's children aged 4 to 6 (unvaccinated) years showed that the lower educational level of father, mother, and family number correlated with increased odds of colonization of children with Hib. CONCLUSION: Our findings showed a significant decrease (60%) in the overall Hib nasopharyngeal carriage in healthy children under six years after 5 years after the start of Hib vaccination.


Subject(s)
Carrier State , Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage , Haemophilus Infections , Haemophilus Vaccines/administration & dosage , Haemophilus influenzae type b/immunology , Nasopharynx , Poliovirus Vaccine, Inactivated/administration & dosage , Vaccination , Carrier State/immunology , Carrier State/microbiology , Carrier State/pathology , Carrier State/prevention & control , Child , Child, Preschool , Cross-Sectional Studies , Diphtheria-Tetanus-Pertussis Vaccine/immunology , Female , Haemophilus Infections/immunology , Haemophilus Infections/pathology , Haemophilus Infections/prevention & control , Haemophilus Vaccines/immunology , Humans , Infant , Iran , Male , Nasopharynx/immunology , Nasopharynx/microbiology , Poliovirus Vaccine, Inactivated/immunology , Vaccines, Combined/administration & dosage , Vaccines, Combined/immunology
15.
Asian Pac J Cancer Prev ; 22(1): 157-161, 2021 Jan 01.
Article in English | MEDLINE | ID: mdl-33507694

ABSTRACT

BACKGROUND: Despite the notable advances in modern surgery and radiotherapy,no significant increase in the five year survival rate of oral squamous cell carcinoma has been reported. Collecting evidence demonstrates that miR 153 and miR 455-5p play a key role in growth and progression of oral cancer. Early detection of OSCC is important for enhancing patient quality of life and clinical treatment.For this reason, biomarkers or tumour markers offer an opportunity to intervene and avoid development of oral cancer. METHODS: A total of 50 blood samples from patients from both genders (25 OSCC and 25 healthy people/control groups) were obtained to determine the expression of miR153 and miR455-5p using Real time Polymerase chain reaction and t test. RESULTS: In general by using the formula Δ ct, it is evident that the miR 153 expression in peripheral blood is lower in patients than in healthy individuals (1.97) while the miR 455-5p expression in peripheral blood is higher in patients than in healthy individuals (2.56). CONCLUSION: We conclude that miR153 and miR 455-5p expression in serum can function as a diagnostic screening test for the early detection of oral squamous cell carcinoma.
.


Subject(s)
Biomarkers, Tumor/genetics , Carcinoma, Squamous Cell/pathology , MicroRNAs/genetics , Mouth Neoplasms/pathology , Adult , Aged , Biomarkers, Tumor/blood , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/genetics , Case-Control Studies , Female , Follow-Up Studies , Gene Expression Regulation, Neoplastic , Humans , Male , MicroRNAs/blood , Middle Aged , Mouth Neoplasms/blood , Mouth Neoplasms/genetics , Prognosis , Quality of Life
16.
Photodiagnosis Photodyn Ther ; 33: 102142, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33307231

ABSTRACT

OBJECTIVES: This study aimed to assess the effect of photodynamic therapy (PDT) on expression of CASP3, NRAS and HRAS genes at mRNA levels, and apoptosis of head and neck squamous cell carcinoma (HNSCC) cell line. MATERIALS AND METHODS: In order to complete the present in vitro study, HNSCC cell line (NCBI C196 HN5) purchased from Pasteur Institute. Cells were divided into four groups; Group 1: photodynamic treatment (laser + methylene blue (MB) as photosensitizer), group 2: MB, group 3: laser (with 660 nm wavelength), and group 4: control (without any treatment). To determine the optimal concentration of MB, in a pilot study, toxicity of MB in different concentration was assessed using MTT assay. Cells in group 1, 2 and 3 was treated at optimal concentration of MB (1.6 µg/mL). Gene expression at mRNA levels was assessed after 24 h incubation, using real-time (qRT)-PCR. The expression of BAX and BCL2 genes at the mRNA levels was analyzed to evaluate apoptosis. 2-ΔΔCt values of BCL2, BAX, CASP3, NRAS, and HRAS in groups was analyzed using ANOVA. Tukey's HSD and Games Howell test was used to compare between two groups. RESULTS: Over-expression of BAX (p < 0.001), CASP3 (p < 0.001) and down-regulation of BCL2 (p = 0.004), HRAS (p = 0.023) and NRAS (p = 0.045) were noted in group 1 (PDT), compared with the control group. Treatment by laser alone induce down-regulation of CASP3 (p < 0.05), BAX (p < 0.05), BCL2 (p > 0.05), HRAS (p > 0.05) and NRAS (p > 0.05). CONCLUSION: PDT caused down-regulation of NRAS, HRAS and BCL2 and over-expression of CASP3 and BAX genes at mRNA levels in HNSCC cell line. The present study raises the possibility that the role of MB on BCL2 down-regulation and BAX and CASP3 over-expression was higher than laser alone while it seems that laser alone was more effective than MB in HRAS and NRAS down-regulation.


Subject(s)
Head and Neck Neoplasms , Photochemotherapy , Apoptosis , Caspase 3 , Cell Line , Cell Line, Tumor , GTP Phosphohydrolases/genetics , GTP Phosphohydrolases/pharmacology , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/genetics , Humans , Membrane Proteins/genetics , Photochemotherapy/methods , Photosensitizing Agents/pharmacology , Pilot Projects , Proto-Oncogene Mas , Proto-Oncogene Proteins p21(ras)/genetics , Proto-Oncogene Proteins p21(ras)/pharmacology , RNA, Messenger , Squamous Cell Carcinoma of Head and Neck/drug therapy , Squamous Cell Carcinoma of Head and Neck/genetics
17.
Iran J Nurs Midwifery Res ; 25(4): 286-290, 2020.
Article in English | MEDLINE | ID: mdl-33014739

ABSTRACT

BACKGROUND: Patients with cancer deal with physical, psychosocial, spiritual, and existential problems that impact on their quality of life. This study aimed to assess the effect of dignity therapy on the quality of life of mentioned patients. MATERIALS AND METHODS: In this quasi-experimental study, 50 patients with cancer hospitalized in a palliative care center in Tehran, Iran, in 2017-18 who fulfilled inclusion criteria were selected through convenience sampling. The European Organization for Research and Treatment of Cancer Quality of Life-C15-Palliative (EORTC-QLQ-C15-PAl) questionnaire was filled by patients before and 2 weeks after dignity therapy. Data were analyzed using descriptive statistics such as frequency, mean, and standard deviation, as well as inferential statistics, including independent t-test and Chi-square test. RESULTS: Results showed that dignity-therapy led to more improvement in the quality of life of the intervention group (t35,18= 4.82, p = 0.001). There was also a significant difference between the two groups in terms of the physical functioning scale (t32,96= -2.60,p = 0.01) and emotional functioning (t 45,69= 6.54, p < 0.001). We also found that dignity-therapy led to more improvement in nausea and vomiting (χ2 = 5.71, p = 0.02), insomnia (χ2 = 15.78, p < 0.001), appetite (χ2 = 5.09, p = 0.02), and constipation (χ2 = 12.50, p < 0.001). CONCLUSIONS: The application of new approaches like-dignity therapy could benefit patients with cancer in terms of reducing their distress, improving symptom severity, physical and emotional functioning, and total quality of life.

18.
J Lasers Med Sci ; 10(3): 211-214, 2019.
Article in English | MEDLINE | ID: mdl-31749948

ABSTRACT

Introduction: The removal of ceramic veneers is a time-consuming procedure in a dental office. Little research has been done in alternative removal techniques for ceramic veneers. The objective of this study was to evaluate the removal of feldspathic and lithium disilicate reinforced glass ceramic veneers by Er, Cr: YSGG and to measure debonding time and pulpal temperature increase during veneer removal. Methods: Fifty-seven bovine incisor teeth were prepared and divided into 3 groups. Ceramic specimens with a thickness of 0.7mm, a width of 4mm and a length of 8 mm were fabricated from feldspathic ceramic, lithium disilicate reinforced glass ceramic HT (high translucency) and lithium disilicate reinforced glass ceramic MO (medium opacity) (19 for each group). Specimens were cemented on the labial surface of incisors using resin cement. The Er, Cr: YSGG laser was applied to each specimen at 2.5 W and 25 Hz. Debonding time was measured for each specimen, and the intrapulpal temperature was detected in 3 specimens for each group. Data were analyzed via one-way analysis of variance (ANOVA) at significance level of 0.05 (α = 0.05). Results: Mean debonding time was 103.68 (26.76), 106.58 (47.22) and 103.84 (32.90) seconds for feldspathic, lithium disilicate MO, and lithium disilicate HT respectively. There was no significant statistical difference among the groups (P value = 0.96). The intrapulpal temperature increase was less than 1°C in all groups. Conclusion: Er, Cr: YSGG can successfully be used to efficiently debond feldspathic and lithium disilicate reinforced glass ceramic veneers. There was no significant difference for debonding time among these ceramic materials. During ceramic laminate veneer removal by laser irradiation, no irritating temperature rise was detected.

19.
Arch Iran Med ; 22(4): 168-173, 2019 04 01.
Article in English | MEDLINE | ID: mdl-31126174

ABSTRACT

BACKGROUND: The Health Belief Model (HBM) as a conceptual framework in health behavior research was applied to improve self-management. This study aimed to determine the effect of theory-based intervention program among women with gestational diabetes mellitus (GDM). METHODS: This quazi-experimental study was conducted on 110 women 17-41 years old which were divided randomly into intervention (n = 55) and control (n = 55) groups. The intervention group received a self-management education for four sessions lasting 35-40 minutes accompanied with a phone call as a booster. Both intervention and control groups attended a routine GDM education program at outpatient health centers. A multi-section instrument included demographics, 28 items in HBM (CVI and CVR were 0.83, 0.87, respectively) and self-management sections. All participants were invited to complete the questionnaire at baseline and at three and six months after intervention. SPSS version 21 was performed for data analysis using repeated measure ANOVA and paired t-test. P less than 0.05 was considered statistically significant. RESULTS: At baseline, demographics and HBM constructs revealed no significant differences between two groups (P>0.05). After intervention, perceived susceptibility, severity, barriers, benefits and self-efficacy revealed significant differences in the intervention group compared with controls (P<0.001). Self-management and HbA1c indicated significant differences in the intervention group before and after three and six months (P<0.001) whereas in the control group no significant differences were revealed (P>0.05). CONCLUSION: Implementing the HBM educational intervention program with focus on benefits of self-management has positive impact on pregnant women.


Subject(s)
Diabetes, Gestational/therapy , Health Education , Health Knowledge, Attitudes, Practice , Self-Management/methods , Adolescent , Adult , Female , Health Behavior , Humans , Pregnancy , Self Efficacy , Surveys and Questionnaires , Young Adult
20.
Curr Ther Res Clin Exp ; 88: 47-51, 2018.
Article in English | MEDLINE | ID: mdl-29928468

ABSTRACT

BACKGROUND: The aim of this study was to evaluate the safety, tolerability, and efficacy of a brand-generic glatiramer acetate product in patients with relapsing-remitting multiple sclerosis over a 12-month period. A noninterventional cohort study was conducted on 185 patients. The patients had a confirmed and documented diagnosis of relapsing-remitting multiple sclerosis as defined by the Revised McDonald Criteria (2010), were ambulatory with a Kurtzke Expanded Disability Status Scale score of 0 to 5.5, and their treatment by glatiramer acetate 40 mg/mL was just started. METHODS: Adverse drug reactions, relapse rate, magnetic resonance imaging parameters, and Expanded Disability Status Scale score were evaluated over 1 year. RESULTS: Of 185 enrolled patients from 21 different cities, 170 completed the study. The mean (SD) Expanded Disability Status Scale score was 1.97 (0.75) at the time of screening. The mean age was 33 years with an average of 4-year multiple sclerosis history, and 83% were women. Hepatic disorder and depression were the most frequent medical history. The most common adverse drug reactions were local pain (45.4%) and erythema (38.9%). The immediate postinjection reactions included dyspnea (10.3%), anxiety (9.7%), palpitation (8.1%), urticaria (5.4%), flushing (3.24%), chest pain (2.16%), and throat constriction (0.54%). The percentage of relapse-free patients at Month 12 was 87%, and the annual relapse rate was 0.134. An increase in the Expanded Disability Status Scale score was observed in 20% of patients, and new T2 and gadolinium-enhancing lesions were found in 34.7% and 9.4%, respectively. The rate of treatment failure was 1.6% and 4.3% according to the Modified Rio and Rio scores, respectively. CONCLUSIONS: The 40 mg brand-generic glatiramer acetate product was well tolerated in this selected group of Iranian patients with relapsing-remitting multiple sclerosis, and patient adherence was favorable over 1 year. (Curr Ther Res Clin Exp. 2018; 79:XXX-XXX).

SELECTION OF CITATIONS
SEARCH DETAIL
...